Pharmacovigilance (PV) is all about detecting medicine safety issues early by processing adverse event reports and health data. But with the massive rise in Individual Case Safety Reports, case processing has become time-consuming, technical, and expensive.
This is where Artificial Intelligence steps in. AI can automate repetitive tasks like data entry, coding, duplicate checks, and extracting details from free text, making the system faster and more efficient.
But here’s the reality: PV is not just data, it’s clinical judgment. Causality assessment and signal detection still need trained human experts.
AI should support pharmacovigilance, not replace it. The real strength lies in combining intelligent technology with human expertise to truly protect patient safety.
Do you think AI can ever fully handle drug safety monitoring, or will human judgment always remain essential?
MBH/AB